BRDs and BETs can inhibit or activate the assembly of the transcriptional machinery regulating the production of inflammatory cytokines with crucial functions in tumor progression (IL-1b, IL-6, TNFa, and MCP-1) [10, 243–246]. The gene discussed is TNF; the disease is neoplasm.